Monitoring of Copper in Wilson Disease

(1) Introduction: Wilson’s disease (WND) is an autosomal recessive disorder of copper (Cu) metabolism. Many tools are available to diagnose and monitor the clinical course of WND. Laboratory tests to determine disorders of Cu metabolism are of significant diagnostic importance. (2) Methods: A system...

Full description

Bibliographic Details
Published in:	Diagnostics
Main Authors:	Grażyna Gromadzka, Marta Grycan, Adam M. Przybyłkowski
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Subjects:	Wilson disease diagnostics copper ceruloplasmin radioactive copper non-ceruloplasmin copper
Online Access:	https://www.mdpi.com/2075-4418/13/11/1830

Similar Items

Wilson’s Disease, Etiology and Treatment
by: Feryal Rada
Published: (2025-01-01)

Wilson’s disease in a child: a difficult path to diagnosis (clinical case)
by: O.M. Вabadzhanian, et al.
Published: (2025-05-01)

Assessment of Serum Copper, Ceruloplasmin, Copper:Ceruloplasmin ratio in Pregnant women in and around of Warangal
by: Pullaiah Akinepalli 1 , Narender Gaddam 2
Published: (2017-12-01)

Biochemical diagnosis of Wilson’s disease: an update
by: Martínez-Morillo Eduardo, et al.
Published: (2022-04-01)

Wilson's disease - clinical picture, factors influencing disease progression, treatment methods
by: Monika Korga, et al.
Published: (2024-07-01)

Relative exchangeable copper: A highly specific and sensitive biomarker for Wilson disease diagnosis
by: Nouzha Djebrani-Oussedik, et al.
Published: (2025-10-01)

Association of variants in the CP, ATOX1 and COMMD1 genes with Wilson disease symptoms in Latvia
by: Zarina A, et al.
Published: (2019-12-01)

Apoceruloplasmin: Abundance, Detection, Formation, and Metabolism
by: Maria C. Linder
Published: (2021-02-01)

Relationship between serum copper & ceruloplasmin level and dependence on sample
by: A GHolan hoseinian, et al.
Published: (1994-09-01)

TDMQ20 as A Drug Candidate for Wilson’s Disease: Comparison with D-Penicillamine, Trientine, and Tetrathiomolybdate In Vitro and In Mice
by: Yingshan Zhu, et al.
Published: (2025-09-01)

Wilson’s disease: A Comprehensive Review of Genetics, Pathophysiology, Clinical Symptoms, Diagnostic Techniques and Current Treatment
by: Natalia Wdowiak, et al.
Published: (2024-10-01)

A functional seizure case in Wilson’s disease
by: Lucas D'Andrea, et al.
Published: (2025-06-01)

Wilson's disease patients with normal ceruloplasmin levels
by: Aysel Yüce, et al.
Published: (1999-01-01)

Wilson's disease update: An Indian perspective
by: Kalyan Bhattacharya, et al.
Published: (2022-01-01)

Wilson's Disease update: An Indian perspective
by: Niraj Kumar, et al.
Published: (2021-01-01)

Wilson’s Disease—Genetic Puzzles with Diagnostic Implications
by: Grażyna Gromadzka, et al.
Published: (2023-03-01)

Comparative Analysis of Serum Ceruloplasmin Levels in Wilson Disease by Conventional Enzymatic Assay and Immunologic Method
by: Rungtip Soi-ampornkul, et al.
Published: (2006-01-01)

Panda Sign: The Defining Feature of Wilson’s Disease
by: Ojas Mahajan, et al.
Published: (2024-02-01)

The Role of Copper in Alzheimer’s Disease Etiopathogenesis: An Updated Systematic Review
by: Angela Sabalic, et al.
Published: (2024-10-01)

Bioinformatics-based dynamics of cuproptosis -related indicators in experimental silicosis
by: Jiarui Xia, et al.
Published: (2024-04-01)

Evaluation of salivary ceruloplasmin for the diagnosis of Wilson’s disease
by: Nian Zhang, et al.
Published: (2025-03-01)

Assessment of the diagnostic value of serum ceruloplasmin for Wilson’s disease in children
by: Xinshuo Lu, et al.
Published: (2022-03-01)

Screening of Wilson’s disease in a psychiatric population: difficulties and pitfalls. A preliminary study
by: Caroline Demily, et al.
Published: (2017-04-01)

Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients
by: Rosanna Squitti, et al.
Published: (2006-01-01)

Serum ceruloplasmin ,copper and iron levels as a risk factors for coronary heart diseases(CHD)
by: Baghdad Science Journal
Published: (2010-03-01)

Wilson’s Disease with Acute Hepatic Onset: How to Diagnose and Treat It
by: Valeria Delle Cave, et al.
Published: (2024-01-01)

Evaluation of Peroxynitrite and Some Chemical Parameters in Sera of Hospital Cleaning Staffs
by: zeyan Abdullah Ali
Published: (2023-12-01)

Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review
by: Tomasz Litwin, et al.
Published: (2023-07-01)

Menkes disease: what a multidisciplinary approach can do
by: Ojha R, et al.
Published: (2016-08-01)

Evaluation of Two Levels of Trace Mineral Supplementation to Beef Calves Prior to Weaning
by: Gracia M. P. Hernandez, et al.
Published: (2024-10-01)

A comparative analysis in monitoring 24-hour urinary copper in wilson disease: sampling on or off treatment?
by: Isabelle Mohr, et al.
Published: (2025-01-01)

Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study
by: Serhat Tunç, et al.
Published: (2019-07-01)

Wilson’s disease
by: Svetel Marina, et al.
Published: (2024-01-01)

Clinical Profile, Laboratory Characteristics and Treatment of Wilson’s Disease in Children from Western India
by: Shailja Vajpayee, et al.
Published: (2024-06-01)

Cu<sup>+</sup>/Ag<sup>+</sup> Competition in Type I Copper Proteins (T1Cu)
by: Nikoleta Kircheva, et al.
Published: (2023-04-01)

Menkes' disease: case report Doença de Menkes: relato de caso
by: Fabio Agertt, et al.
Published: (2007-03-01)

A Case Series of Atypical Neuroimaging Phenotypes in Wilson’s Disease
by: Ashok Narayan, et al.
Published: (2025-05-01)

The Wilson's disease - etiology, symptoms in various organs, diagnosis, treatment, prognosis
by: Patryk Graczyk, et al.
Published: (2025-01-01)

Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson’s Phenotype Development
by: Marina N. Karpenko, et al.
Published: (2023-08-01)

Research progress in ceruloplasmin regulation of lipid metabolism homeostasis
by: JIANG Quanxin, et al.
Published: (2024-01-01)